Giuseppe Remuzzi

Giuseppe Remuzzi

scientist Italy

Giuseppe Remuzzi is the director of the Mario Negri Institute for Pharmacological Research in Italy and a renowned nephrologist. He has gained recognition for his research in kidney diseases and the role of various dietary practices on health outcomes. Recently, he was in the news for his commentary on an American study that challenges the health benefits of intermittent fasting, particularly the '16:8' method, suggesting it may increase cardiovascular risks rather than promote longevity.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Italy Italy: Giuseppe Remuzzi is the director of the Mario Negri Institute and comments on the safety of paracetamol during pregnancy. 8

Corriere della Sera: Autismo e paracetamolo in gravidanza, Remuzzi: «Nessun aumento del rischio, rimane il farmaco più sicuro»

Italy Italy: Professor Giuseppe Remuzzi expresses concern over the consequences of funding cuts on pandemic preparedness. 6

Corriere della Sera: Remuzzi: «I tagli di Kennedy Jr ai vaccini? Una mossa che può impedirci di affrontare future pandemie»

Italy Italy: Giuseppe Remuzzi is the director of the Mario Negri Institute for Pharmacological Research and a professor of Nephrology at the University of Milan. 4

Corriere della Sera: Il digiuno intermittente può nuocere alla salute: lo studio americano. Remuzzi: «Effetti a breve termine positivi. E poi?»